Details for New Drug Application (NDA): 075989
✉ Email this page to a colleague
The generic ingredient in LORATADINE AND PSEUDOEPHEDRINE SULFATE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 075989
Tradename: | LORATADINE AND PSEUDOEPHEDRINE SULFATE |
Applicant: | Perrigo Pharma Intl |
Ingredient: | loratadine; pseudoephedrine sulfate |
Patents: | 0 |
Pharmacology for NDA: 075989
Mechanism of Action | Adrenergic alpha-Agonists |
Suppliers and Packaging for NDA: 075989
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LORATADINE AND PSEUDOEPHEDRINE SULFATE | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 075989 | ANDA | Walgreen Company | 0363-2010 | 0363-2010-22 | 15 BLISTER PACK in 1 CARTON (0363-2010-22) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
LORATADINE AND PSEUDOEPHEDRINE SULFATE | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 075989 | ANDA | Kroger Company | 30142-846 | 30142-846-22 | 15 BLISTER PACK in 1 CARTON (30142-846-22) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MG;240MG | ||||
Approval Date: | Mar 4, 2004 | TE: | RLD: | No |
Complete Access Available with Subscription